Available Until 9/19/2023

Pediatric Pharmacy Specialty Core Therapeutic Module Package for Recertification (Cert # L229269)

ACPE Numbers: Various – see listing below
Pre-Sale Date: 08/31/2022
Content Release Date: 09/21/2022
Expiration Date: 09/19/2023
Activity Type: Application-based
CE Credits: 3.0 (BPS and ACPE) contact hours
Activity Fee: $100 (ASHP member); $150 (non-member)

Activity Overview

The Core Therapeutic Modules for Recertification Package consists of 3 activities (see table below). In each activity, faculty review clinical topics and practice skills using a case-based approach. This package is intended for board certified pharmacists in need of recertification credit; the activities were designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). 

Each activity is approved for 1.0 contact hour(s) of continuing pharmacy education credit. Successful completion of all the learning modules will provide up to 3.0 contact hours of continuing pharmacy education credit.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  

These activities are intended for Board Certified Pediatric Pharmacy Specialists in need of recertification credit. 

Board certified pharmacists are eligible to receive 3.0 contact hours of recertification credit for completing this module. To earn recertification credit, learners must review the activity content and successfully complete the online assessment by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Participants who pass the assessments will be eligible for recertification credit in the year in which the assessment was completed. 

These activities are part of the ASHP professional development program for BCPPS recertification approved by the BPS. 

Learning Activity

ACPE Number

Contact Hours

Select Topics in Pediatric Cardiovascular Disease

0204-0000-22-630-H01-P

1 ACPE

Select Topics in Pediatric Infectious Diseases Part 1

0204-0000-22-631-H01-P

1 ACPE

Select Topics in Pediatric Neurology Part 2 - Focus on Seizures

0204-0000-22-632-H01-P

ACPE

  →   Recertification Assessment: Core Therapeutic Modules (76% passing score required)

3 BPS

After participating in these CPE activities, learners should be able to:

Select Topics in Pediatric Cardiovascular Disease
ACPE #: 0204-0000-22-630-H01-P

  • Interpret signs, symptoms and diagnostic tests in a pediatric patient with congenital heart disease (specifically VSD, ASD, TOF, coarctation of aorta, and hypoplastic left heart) or Kawasaki disease
  • Identify drug-related problems, including drug interactions.
  • Develop the most appropriate therapy and monitoring plans based on patient-specific information and the most current guidelines.
  • Use PALS to determine appropriate therapy for bradycardia and tachycardia. 

Select Topics in Pediatric Infectious Diseases Part 1
ACPE #: 0204-0000-22-631-H01-P

  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a well-appearing febrile infant.
  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with otitis media.
  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with bronchiolitis.
  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with tuberculosis.
  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with meningitis.
  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with pneumonia. 

Select Topics in Pediatric Neurology Part 2 - Focus on Seizures
ACPE #: 0204-0000-22-632-H01-P

  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with febrile seizures, neonatal seizures, infantile spasms, absence seizures, and Lennox-Gastaut syndrome.
  • Evaluate patients for drug-related problems.
  • Identify appropriate modifications of patient-specific treatment plans based on follow up assessment.

Faculty bios

Teia Brandenburg, PharmD, BCPPS
Clinical Pharmacist – Child Neurology
University of Kentucky Healthcare
Lexington, Kentucky 

Michelle Kussin, PharmD, BCOP
Clinical Pharmacist, Pediatric Infectious Diseases
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana 

Ashley Nebbia, PharmD, BCCPS
Emergency Medicine Clinical Pharmacist
Golisano Children’s Hospital of SW Florida
Fort Myers, Florida

Jamie L. Miller, PharmD, BCPPS, BCPS, FPPAG*
Professor
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma 

Jennifer Thackray, PharmD, BCPPS, BCPS*
Pediatric Oncology Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, New York

*Content Matter Experts

Michelle Abalos, PharmD
Kristi Hofer, PharmD

Mei Bell, PharmD, BCPS
Olivia Brandner, PharmD, BCPPS
Melissa Cook, PharmD, BCPPS
Mackenzie DeVine, PharmD, BCPPS
Sarah Hale, PharmD, BCPPS, BCPS
Samantha Hanna, PharmD, BCPPS
Lane Nguyen, PharmD, BCPPS
Seema Patel, PharmD, MMI, BCPPS, APhA
Susan Villegas, PharmD, BCPPS
Lynn Warner, PharmD, BCPPS
Stephanie Weightman, PharmD, BCPS, BCPPS 

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity. 

All planners, presenters, and reviewers of this session report no financial relationships relevant to this activity. 

Activities which can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations.  Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

These activities were developed by ASHP.